Cammarota, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 10.539
NA - Nord America 7.875
AS - Asia 1.736
Continente sconosciuto - Info sul continente non disponibili 31
SA - Sud America 31
AF - Africa 29
OC - Oceania 14
Totale 20.255
Nazione #
US - Stati Uniti d'America 7.806
DE - Germania 5.003
SE - Svezia 1.458
CN - Cina 1.195
IT - Italia 1.081
UA - Ucraina 811
FR - Francia 482
IE - Irlanda 452
GB - Regno Unito 440
PL - Polonia 308
FI - Finlandia 205
IN - India 189
TR - Turchia 136
BE - Belgio 70
JP - Giappone 55
RU - Federazione Russa 55
CA - Canada 51
NL - Olanda 39
ES - Italia 33
SG - Singapore 33
IR - Iran 31
EU - Europa 27
HK - Hong Kong 24
CH - Svizzera 21
CZ - Repubblica Ceca 21
BR - Brasile 17
VN - Vietnam 14
AU - Australia 12
RO - Romania 12
AT - Austria 11
CI - Costa d'Avorio 10
IL - Israele 10
TN - Tunisia 10
KR - Corea 9
MX - Messico 9
PT - Portogallo 8
CL - Cile 7
AE - Emirati Arabi Uniti 5
HR - Croazia 5
BZ - Belize 4
CO - Colombia 4
LK - Sri Lanka 4
NO - Norvegia 4
PK - Pakistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CY - Cipro 3
DZ - Algeria 3
GR - Grecia 3
HU - Ungheria 3
PH - Filippine 3
RS - Serbia 3
ZA - Sudafrica 3
AL - Albania 2
CR - Costa Rica 2
IQ - Iraq 2
KW - Kuwait 2
LT - Lituania 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
TW - Taiwan 2
YE - Yemen 2
A1 - Anonimo 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CU - Cuba 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
GE - Georgia 1
GL - Groenlandia 1
ID - Indonesia 1
KZ - Kazakistan 1
MC - Monaco 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
QA - Qatar 1
SC - Seychelles 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 20.255
Città #
Chandler 1.761
Ashburn 632
Jacksonville 480
Dublin 449
San Mateo 381
Nürnberg 378
Ann Arbor 357
Nanjing 296
Woodbridge 229
Wilmington 223
Warsaw 217
Boston 197
Cattolica 183
Dearborn 167
New York 166
Marseille 165
Princeton 151
Milan 149
Fairfield 136
Izmir 129
Redwood City 124
Munich 120
Rome 120
Seattle 118
Houston 114
Nanchang 111
Beijing 109
Lawrence 87
Kraków 75
Shenyang 73
Hangzhou 66
Fuzhou 65
Brussels 63
Redmond 59
Bremen 56
Hebei 54
Mountain View 54
Verona 54
Lancaster 53
Leawood 52
Chicago 51
Kunming 47
University Park 44
Zhengzhou 44
Pune 42
Cambridge 40
Changsha 40
Shanghai 40
Tianjin 40
Boardman 39
Helsinki 38
Norwalk 37
Fremont 36
Guangzhou 35
Jiaxing 32
Augusta 29
Falls Church 29
Jinan 23
London 21
Singapore 20
Detroit 19
Los Angeles 19
Kish 16
Andover 15
Hong Kong 15
Washington 15
Edinburgh 14
Lanzhou 14
San Jose 14
Costa Mesa 13
Simi Valley 13
Ottawa 12
Paris 12
San Francisco 12
Toronto 12
Ningbo 11
Abidjan 10
Busto Arsizio 10
Hefei 10
Phoenix 10
San Diego 10
Taizhou 10
Trieste 10
Hanoi 9
Indiana 9
Tokyo 9
Vienna 9
Xian 9
Zurich 9
Amsterdam 8
Brno 8
Changchun 8
Chengdu 8
Monmouth Junction 8
Mumbai 8
Parma 8
Groningen 7
Seoul 7
Bari 6
Berlin 6
Totale 9.632
Nome #
-Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth 440
A case-control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients 374
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns 372
Small intestinal bacterial overgrowth recurrence after antibiotic therapy 354
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 291
gc) Water-immersion technique during standard upper endoscopy may be useful to drive the biopsy sampling of duodenal mucosa in children with celiac disease. 246
A) Lack of endoscopic visualization of intestinal villi with the "immersion technique" in overt atrophic celiac disease 204
Wheat desensitization treatment in patients with gluten sensitivity 195
ag)Association between hypothyroidism and small intestinal bacterial overgrowth 194
High accuracy and cost-effectiveness of a biopsy-avoiding endoscopic approach in diagnosing coeliac disease. 193
A highly accurate method for monitoring histological recovery in patients with celiac disease on a gluten-free diet using an endoscopic approach that avoids the need for biopsy: a double-center study 185
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 179
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 177
gc) Patchy left-sided colitis: primary eosinophilic colitis or paraneoplastic syndrome ? 174
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy 169
gc) Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. 166
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study 166
-High prevalence of celiac disease in patients with lactose intolerance 165
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 156
GC)Optimal band imaging system: a new tool for enhancing the duodenal villous pattern in celiac disease. 150
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 149
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study. 149
A) Reliability of the "immersion technique" during routine upper endoscopy for detection of abnormalities of duodenal villi in patients with dyspepsia. 147
Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota 146
A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. 140
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 140
The role of diet on gut microbiota composition 133
. Adverse reactions to food: allergies and intolerances. 127
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 127
Diagnostic and therapeutic impact of double-balloon enteroscopy (DBE) in a series of 100 patients with suspected small bowel diseases 126
Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes 125
Can chronic gastritis cause an increase in fecal calprotectin concentrations? 125
Dramatic improvement of parkinsonian symptoms after gluten-free diet introduction in a patient with silent celiac disease 125
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns 124
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 124
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 123
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 123
Can chronic gastritis cause increase of fecal calprotectin concentrations? 122
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 120
-Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. 119
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study 119
Celiac disease: what's new about it? 118
(gc)Association of laryngeal cancer with previous gastric resection. 118
Fecal microbiota transplantation: Past, present and future perspectives 118
A) High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. 117
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns. 117
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 115
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 114
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 113
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 113
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. 112
-Double-balloon enteroscopy for diagnosis of a Meckel's diverticulum in a patient with GI bleeding of obscure origin 112
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 111
[Helicobacter pylori infection: from gastric to systemic disease] 110
gc) Tired legs a gut diagnosis 110
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy 110
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 107
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 107
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 106
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 105
-Accuracy of laryngeal examination during upper gastrointestinal endoscopy for premalignancy screening: prospective study in patients with and without reflux symptoms. 104
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders 104
A) Association of laryngeal cancer with previous gastric resection 103
(gc) Direct visualization of intestinal villi by high-resolution magnifying upper endoscopy: a validation study 103
-Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth 103
Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment 102
ag) Fecal calprotectin in first-degree relatives of patients with ulcerative colitis. 102
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 102
Levofloxacin based regimens for the eradication of Helicobacter pylori 101
A) Gastric surgery as a long-term risk factor for malignant lesions of the larynx. 101
Classification of malabsorption syndromes. 100
Faecal calprotectin concentrations in untreated coeliac patients 100
Celiac disease and chronic urticaria resolution: a case report. 100
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 99
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 98
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. 97
Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection 97
gastroesophageal reflux disease: facts and uncertaines 96
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 96
Reflux symptoms in wind instrument players. 95
Moderately Severe Acute Pancreatitis Associated With Riluzole 95
Gluten-related Recurrent Peripheral Facial Palsy 94
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 93
Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. 93
Fecal calprotectin in first-degree relatives of patients with ulcerative colitis 93
Microscopic colitis 93
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 93
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 93
Prophylactic aspirin therapy does not increase faecal calprotectin concentrations. 92
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study 92
. Quick test: a new test for the diagnosis of duodenal hypolactasia. 91
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 91
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 91
Link between Helicobacter pylori infection and iron-deficiency anaemia in patients with coeliac disease 90
An Attempt of Specific Desensitizing Treatment with Gliadin in Coleliac Disease 89
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 89
Current technologies for the endoscopic assessment of duodenal villous pattern in celiac disease 89
Role of N-acetyl-cisteine in the treatment of H. pylori 88
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 88
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 86
Totale 13.242
Categoria #
all - tutte 65.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019662 0 0 0 0 0 0 0 0 0 201 273 188
2019/20203.247 552 243 207 191 268 311 425 129 209 202 310 200
2020/20212.093 112 234 52 192 268 170 229 54 232 91 392 67
2021/20222.085 117 184 57 129 130 89 39 336 97 95 385 427
2022/20234.831 624 655 363 730 314 592 246 384 593 88 154 88
2023/20241.940 131 695 85 169 116 313 173 95 68 95 0 0
Totale 20.563